1. Home
  2. ADMA vs AVAL Comparison

ADMA vs AVAL Comparison

Compare ADMA & AVAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • AVAL
  • Stock Information
  • Founded
  • ADMA 2004
  • AVAL 1994
  • Country
  • ADMA United States
  • AVAL Colombia
  • Employees
  • ADMA N/A
  • AVAL N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • AVAL Commercial Banks
  • Sector
  • ADMA Health Care
  • AVAL Finance
  • Exchange
  • ADMA Nasdaq
  • AVAL Nasdaq
  • Market Cap
  • ADMA 3.7B
  • AVAL 3.4B
  • IPO Year
  • ADMA N/A
  • AVAL N/A
  • Fundamental
  • Price
  • ADMA $14.50
  • AVAL N/A
  • Analyst Decision
  • ADMA Strong Buy
  • AVAL
  • Analyst Count
  • ADMA 3
  • AVAL 0
  • Target Price
  • ADMA $27.67
  • AVAL N/A
  • AVG Volume (30 Days)
  • ADMA 3.4M
  • AVAL 61.6K
  • Earning Date
  • ADMA 11-06-2025
  • AVAL 11-14-2025
  • Dividend Yield
  • ADMA N/A
  • AVAL 2.90%
  • EPS Growth
  • ADMA 469.09
  • AVAL 233.52
  • EPS
  • ADMA 0.85
  • AVAL 0.02
  • Revenue
  • ADMA $474,174,000.00
  • AVAL $3,198,162,589.00
  • Revenue This Year
  • ADMA $21.17
  • AVAL $46.54
  • Revenue Next Year
  • ADMA $26.03
  • AVAL $8.90
  • P/E Ratio
  • ADMA $17.31
  • AVAL $10.64
  • Revenue Growth
  • ADMA 43.58
  • AVAL 21.28
  • 52 Week Low
  • ADMA $13.50
  • AVAL $1.96
  • 52 Week High
  • ADMA $25.67
  • AVAL $3.51
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 30.18
  • AVAL 55.60
  • Support Level
  • ADMA $14.43
  • AVAL $3.20
  • Resistance Level
  • ADMA $15.38
  • AVAL $3.50
  • Average True Range (ATR)
  • ADMA 0.48
  • AVAL 0.10
  • MACD
  • ADMA -0.10
  • AVAL 0.00
  • Stochastic Oscillator
  • ADMA 3.57
  • AVAL 67.11

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)

Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its segments include: Banking Services segment comprises Banking Services, fund management and trust businesses, storage companies and entities that manage low-value payment systems. Merchant Banking segment comprises Financial Sector (trust and brokerage), Gas and Energy Sector (includes natural gas and energy transportation and distribution businesses), Infrastructure Sector (includes road infrastructure projects, construction services, and operation and maintenance), Hotel Sector (includes hospitality services), Agribusiness Sector (includes palm oil, rubber and rice businesses). Pension and Severance Fund Management" segment comprise administrator of pension and severance funds; and Holding segment.

Share on Social Networks: